Zhang Hongbo, Chen Hao, Niu Jingyi, Wang Yiqiang, Xie Lixin
Qingdao University-SEI Joint Immunology Program, 2Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Qingdao, China.
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2653-9. doi: 10.1167/iovs.08-3104. Epub 2009 Feb 14.
Innate immunity had been thought to be critical in the pathogenesis and prognosis of fungal keratitis. This study was conducted to determine whether experimental Candida albicans keratitis (CaK) induces an adaptive immune response.
Experimental murine CaK was induced by intrastromal injection of C. albicans spores, and fungal pneumonia was induced by intranasal inhalation of spores. Active immunization was accomplished by subcutaneous injection of heat-inactivated spores. Serum was collected at different times after the induction of primary or secondary CaK for the measurement of IgA, IgG, IL-4, and IFN-gamma. Immunohistochemistry was used to detect immunoglobulin deposition and lymphocyte infiltration in diseased corneas.
After intrastromal injection of C. albicans spores in immunocompetent mice, typical CaK occurred, and the corneas healed in 3 weeks. When recovered corneas were challenged again with spores, they developed milder CaK and healed faster than with primary CaK. Mice that had recovered from pulmonary infection or had been immunized also showed increased resistance to CaK. Compared with naive mice, the mice that had previously encountered C. albicans produced more IgG and IgA in serum and more immunoglobulin deposition and lymphocyte infiltration in corneas on secondary CaK induction. Cytokines assays showed that the immune response induced by CaK was biased toward the T-helper (Th)1 type.
Th1-type adaptive immune response and immunologic memory were induced by C. albicans keratitis, and previous contact with Candida preparation enhanced the resistance of the host to subsequent corneal challenge with the same fungus. Active immunization might be an effective strategy to prevent fungal keratitis in populations at high risk.
先天性免疫被认为在真菌性角膜炎的发病机制和预后中起关键作用。本研究旨在确定实验性白色念珠菌角膜炎(CaK)是否能诱导适应性免疫反应。
通过基质内注射白色念珠菌孢子诱导实验性小鼠CaK,通过鼻内吸入孢子诱导真菌性肺炎。通过皮下注射热灭活孢子实现主动免疫。在原发性或继发性CaK诱导后的不同时间收集血清,以测量IgA、IgG、IL-4和IFN-γ。采用免疫组织化学检测病变角膜中的免疫球蛋白沉积和淋巴细胞浸润。
在免疫活性小鼠基质内注射白色念珠菌孢子后,出现典型的CaK,角膜在3周内愈合。当恢复的角膜再次受到孢子攻击时,它们发生的CaK较轻,愈合速度比原发性CaK更快。从肺部感染中恢复或已免疫的小鼠对CaK的抵抗力也有所增强。与未接触过的小鼠相比,先前接触过白色念珠菌的小鼠在继发性CaK诱导时血清中产生更多的IgG和IgA,角膜中免疫球蛋白沉积和淋巴细胞浸润更多。细胞因子检测表明,CaK诱导的免疫反应偏向于辅助性T细胞(Th)1型。
白色念珠菌角膜炎可诱导Th1型适应性免疫反应和免疫记忆,先前接触念珠菌制剂可增强宿主对随后相同真菌角膜攻击的抵抗力。主动免疫可能是预防高危人群真菌性角膜炎的有效策略。